Report Feature
The future of the DNA diagnostic market looks promising with opportunities in applications, such as pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/p450 effects. The global DNA diagnostic market is expected to grow with a CAGR of 9%-12% from 2020 to 2025. The major drivers for this market are continuous product modifications, increased preference for efficient diagnostic platforms, and increased research & development activities.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global DNA diagnostic market report, please download the report brochure.
In this market, instruments is the largest product of DNA diagnostic, whereas infectious disease is the largest application. Growth in various segments of the DNA diagnostic market are given below:
The study includes trends and forecast for the global DNA diagnostic market by product, technology, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Instruments
Reagents
Service & Software
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Microarray Based
PCR (Polymerase Chain Reaction) Based
In-situ Hybridization
NGS (Next Generation Sequencing) DNA Diagnosis
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Pre-Natal DNA Carrier Screening
Pre-Implantation Diagnosis
Newborn Genetic Screening
Infectious Disease Diagnostics
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the DNA diagnostics model companies profiled in this report include GE Healthcare, Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, Thermo Fisher Scientific, Illumina, Cephide, Hologic, Transgenomic, Siemens Healthcare, Roche Diagnostics, and Qiagen.
Lucintel forecasts that instruments will remain the largest product segment over the forecast period due to improved healthcare facilities, availability of user-friendly instruments, their competitive cost structure, reliability, and size.
Within this market, infectious disease diagnostics will remain the largest application segment over the forecast period due to the increasing prevelance of infectious diseases, advantages of DNA testing in infectious diseases for early detection, and technological advancement for diagnostic application.
North America will remain the largest region over the forecast period due to the presence of sophisticated healthcare infrastructure, strong government initiatives, proactive funding for DNA testing research, and high prevalence of chronic diseases in the region.
|
Features of the Global DNA Diagnostic Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global DNA diagnostic market by product (instruments, reagents, and service & software), technology (microarray based, PCR based, in-situ hybridization, and NGS DNA diagnosis), application (pre-natal DNA carrier screening, pre-implantation diagnosis, newborn genetic screening, infectious disease diagnostics, oncology diagnostics & histopathology, identity diagnostics & forensics, and pharmacogenomics diagnostic testing & drug metabolism/P450 effects), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global DNA diagnostic market? Q.5 What are the business risks and threats to the global DNA diagnostic market? Q.6 What are the emerging trends in this DNA diagnostic market and the reasons behind them? Q.7 What are some changing demands of customers in this DNA diagnostic market? Q.8 What are the new developments in this DNA diagnostic market? Which companies are leading these developments? Q.9 Who are the major players in this DNA diagnostic market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this DNA diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global DNA diagnostic market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product Type (Instruments, Reagents, and Service & Software), Technology (Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis), and Application (Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P450 Effects) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global DNA Diagnostic Market
4.1 Global DNA Diagnostic Market by Region
4.2.1 Market by Product: Instruments, Reagents, and Service & Software
4.2.2 Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.2.3 Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.2.4 The United States DNA Diagnostic Market
4.2.5 The Canadian DNA Diagnostic Market
4.2.6 The Mexican DNA Diagnostic Market
4.3.1 Market by Product: Instruments, Reagents, and Service & Software
4.3.2 Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.3.3 Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.3.4 The United Kingdom DNA Diagnostic Market
4.3.5 The Spanish DNA Diagnostic Market
4.3.6 The German DNA Diagnostic Market
4.3.7 The French DNA Diagnostic Market
4.4.1 Market by Product: Instruments, Reagents, and Service & Software
4.4.2 Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.4.3 Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.4.4 The Chinese DNA Diagnostic Market
4.4.5 The Indian DNA Diagnostic Market
4.4.6 The Japanese DNA Diagnostic Market
4.5.1 Market by Product: Instruments, Reagents, and Service & Software
4.5.2 Market by Technology: Microarray Based, PCR Based, In-situ Hybridization, and NGS DNA Diagnosis
4.5.3 Market by Application: Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics, Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, and Pharmacogenomics Diagnostic Testing & Drug Metabolism/P45
4.5.4 Brazilian DNA Diagnostic Market
7.1.1 Growth Opportunities for the Global DNA Diagnostic Market by Product
7.1.2 Growth Opportunities for the Global DNA Diagnostic Market by Technology
7.1.3 Growth Opportunities for the Global DNA Diagnostic Market by Application
7.1.4 Growth Opportunities for the Global DNA Diagnostic Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
